GINGER WILLIAMS: Open Payments
NPI 1013745405 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,220 in 97 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $457 · 2025 $2,220
Food & beverage: $2,120Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $208 |
| Daiichi Sankyo Inc. | 7 | $185 |
| Exelixis Inc. | 4 | $160 |
| Genentech USA, Inc. | 10 | $145 |
| ABBVIE INC. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| Stemline Therapeutics Inc. | 4 | $96 |
| GENZYME CORPORATION | 3 | $91 |
| GlaxoSmithKline, LLC. | 4 | $86 |
Products named: CABOMETYX, Enhertu, JAKAFI, Orserdu, KEYTRUDA, Nubeqa, JEMPERLI, FOTIVDA.
Industry payments across LA — which companies pay providers there.
